Short answer
agilon health, inc. (AGL) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $1.5B (up 7.2% year over year) with net income of $18M.
Q2 2026 key financials · XBRL
- Revenue
- $1.5B
- +7.2% YoY · +5.2% QoQ
- Net income
- $18M
- +117.2% YoY · −63.3% QoQ
- Operating margin
- 0.8%
- EPS (diluted)
- $1.02
- −65.3% QoQ
Source: XBRL data from the agilon health, inc. (AGL) Q2 2026 10-Q on SEC EDGAR. USD.
agilon health, inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- No profitability or margin percentages disclosed in the excerpt
- Headwinds: medical costs exceeding revenue, membership reductions, payor dependence, healthcare regulation, management transition risks
Risk Factors
- No material changes to 10-K risk factors for quarter ended June 30, 2026
- No newly added risk factor or triggering event disclosed
- No material regulatory, legal, compliance, operational, competitive, market, or financial risk updates disclosed
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other agilon health, inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.